EUVIMEDEUVIMED entdecken
Crossref

Investigation into in silico and in vitro approaches for inhibitors targeting MCM10 in Leishmania donovani: a comprehensive study

Satabdi Saha, Anupama Sharma, Deep Bhowmik, Diwakar Kumar

Molecular Diversity · 2025

DOI: 10.1007/s11030-024-10876-y ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Diversity, 2025. Verfasst von Satabdi Saha und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Assam University, Silchar, 788011, Assam, India. Hauptthemen laut MEDLINE: Leishmania donovani, Antiprotozoal Agents, Protozoan Proteins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 71 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Visceral Leishmaniasis (VL), the second neglected tropical disease caused by various Leishmania species, presents a significant public health challenge due to limited treatment options and the absence of vaccines. The agent responsible for visceral leishmaniasis, also referred to as "black fever" in India, is Leishmania donovani. This study focuses on L. donovani Minichromosome maintenance 10 (LdMcm10), a crucial protein in the DNA replication machinery, as a potential therapeutic target in Leishmania therapy using in silico and in vitro approaches. We employed bioinformatics tools, molecular docking, and molecular dynamics simulations to predict potential inhibitors against the target protein. The research revealed that the target protein lacks homologues in the host, emphasizing its potential as a drug target. Ligands from the DrugBank database were screened against LdMcm10 using PyRx software. The top three compounds, namely suramin, vapreotide, and pasireotide, exhibiting the best docking scores, underwent further investigation through molecular dynamic simulation and in vitro analysis. The observed structural dynamics suggested that LdMcm10-ligand complexes maintained consistent binding throughout the 300 ns simulation period, with minimal variations in their backbone. These findings suggest that these three compounds hold promise as potential lead compounds for developing new drugs against leishmaniasis. In vitro experiments also demonstrated a dose-dependent reduction in L. donovani viability for suramin, vapreotide, and pasireotide, with computed IC50 values providing quantitative metrics of their anti-leishmanial efficacy. The research offers a comprehensive understanding of LdMcm10 as a drug target and provides a foundation for further investigations and clinical exploration, ultimately advancing drug discovery strategies for leishmaniasis treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leishmania donovaniAntiprotozoal AgentsProtozoan ProteinsMolecular Docking SimulationMolecular Dynamics SimulationLigandsComputer Simulation

Stichwörter der Autor:innen

DNA replicationLeishmaniasisMTT assayMinichromosome maintenance 10 (Mcm10)Molecular dynamics simulationVirtual screening

Substanzen

Antiprotozoal AgentsLigandsProtozoan Proteins

Autor:innen und Institutionen

  • Department of Microbiology, Assam University, Silchar, 788011, Assam, India.
  • Department of Computational Sciences, Central University of Punjab, Bathinda, 151401, Punjab, India.
  • Department of Microbiology, Assam University, Silchar, 788011, Assam, India. diwakar11@gmail.com.

Zitieren

APA

Saha, S., Sharma, A., Bhowmik, D., & Kumar, D. (2025). Investigation into in silico and in vitro approaches for inhibitors targeting MCM10 in Leishmania donovani: a comprehensive study. Molecular Diversity. https://doi.org/10.1007/s11030-024-10876-y

Vancouver

Saha S, Sharma A, Bhowmik D, Kumar D. Investigation into in silico and in vitro approaches for inhibitors targeting MCM10 in Leishmania donovani: a comprehensive study. Molecular Diversity. 2025. doi:10.1007/s11030-024-10876-y

BibTeX
@article{Saha2025,
  author = {Saha, Satabdi and Sharma, Anupama and Bhowmik, Deep and Kumar, Diwakar},
  title = {Investigation into in silico and in vitro approaches for inhibitors targeting MCM10 in Leishmania donovani: a comprehensive study},
  journal = {Molecular Diversity},
  year = {2025},
  doi = {10.1007/s11030-024-10876-y}
}
Kostenlos starten →